Whole-cell vs Acellular Pertussis Vaccine
On this page
Direct answer
Whole-cell and acellular pertussis vaccines both protect against Bordetella pertussis, but the whole-cell product is more reactogenic, causing more fever and local swelling. Acellular vaccines contain purified antigens, so their reactions are milder, while protection in the primary series is broadly comparable between the two products, so the choice rests mainly on tolerability.
What you must remember
- Whole-cell (wP): killed whole Bordetella pertussis organisms, with more endotoxin content that drives reactions.
- Acellular (aP): purified antigens such as pertussis toxoid and filamentous haemagglutinin, with fewer local and systemic reactions.
- Reactogenicity: whole-cell vaccine causes more fever, pain and swelling, and febrile convulsions are a recognised but uncommon event.
- Indian infant schedule: the pentavalent vaccine contains whole-cell pertussis, given at six, ten and fourteen weeks.
- Contraindication: encephalopathy not attributable to another cause, within seven days of a pertussis-containing dose, bars further doses.
- Tdap: a booster with reduced diphtheria and pertussis content, used in adolescents, adults and in pregnancy.
- Waning immunity: protection from childhood doses declines, which leaves adolescents and adults susceptible to a prolonged cough.
- Infant risk: infants under six months carry the highest risk of severe pertussis, including apnoea and pneumonia.
Comparing the two products across the schedule
A mother asks whether her infant should receive the acellular version, which would cause fewer side effects. The answer depends on the product the programme supplies and the schedule being followed.
| Feature | Whole-cell (wP) | Acellular (aP) |
|---|---|---|
| Antigen | Killed whole organisms | Purified antigens |
| Reactogenicity | Higher | Lower |
| Primary series protection | Broadly comparable | Broadly comparable |
| Common setting | Many low and middle-income programmes | Most high-income programmes |
Schedules should use the product the programme supplies, and the reaction profile is the main difference students need to remember. Infants start the series at six weeks, and the early months carry the highest risk of death from pertussis.
Adolescents and adults need acellular boosters because waning immunity leaves them open to pertussis. The illness is often mistaken for a simple chronic cough, so a persistent cough in an older person deserves a pertussis history. Tdap is given in adolescence and, in many national guidelines, in late pregnancy so that the newborn receives maternal antibodies before its own vaccines.
Where the exam tries to catch you
Pertussis questions usually test reactogenicity, contraindications and the age groups that receive Tdap.
- Trap: calling acellular vaccines more effective than whole-cell Correct: protection in the primary series is broadly comparable, and the main difference is reactogenicity.
- Trap: thinking pertussis is a childhood-only illness that cannot be severe in adults Correct: waning immunity leaves adolescents and adults susceptible, and the cough can persist for weeks.
- Trap: repeating a pertussis dose after encephalopathy within seven days Correct: that is a contraindication to further pertussis-containing doses under standard guidance.
Frequently asked questions
Why is whole-cell pertussis vaccine more reactogenic?
Whole-cell pertussis vaccine contains killed whole organisms with more endotoxin content, which drives more fever and local swelling. Acellular pertussis vaccines contain only purified antigens, so their reactions are usually milder.
Which pertussis product does India's routine infant schedule use?
India's routine infant schedule uses the whole-cell pertussis component in the pentavalent vaccine, given at six, ten and fourteen weeks. Booster doses follow in the second year and in later childhood, as set out in the national schedule.
When is encephalopathy after a pertussis dose a contraindication?
Encephalopathy that is not attributable to another cause and occurs within seven days of a pertussis-containing dose is a contraindication to further doses. Examiners often test this rule, which applies to the pertussis component of the vaccine.
Why is Tdap given to adolescents and pregnant women?
Protection from childhood pertussis wanes with time, so adolescents and adults become susceptible. Tdap boosts that protection, and in many national guidelines it is given in late pregnancy so that the newborn gains maternal antibodies.
Why is pertussis most dangerous in infants under six months?
Infants under six months are at highest risk of severe disease, including apnoea and pneumonia. They are also too young to be fully protected, since the primary series begins at about six weeks.